[CNNT Membership Roster] [CNNT Meeting Rosters]

The Clinical Neuroplasticity and Neurotransmitters  (CNNT) Study Section reviews applications from the perspective of neurotransmitters and neurotrophic  factors. The areas covered are neurodegeneration (Parkinson’s disease, ALS, neuropathies) spinal cord injuries and epilepsy. The study section evaluates predominantly small animal models.  Specific areas covered by CNNT:

• Neurotransmittter metabolism , receptor regulation at the molecular level, abanormalities of synaptic physiology; role of neurotrophins, growth factors, imaging in small animal models of neurotransmitter and neurotrophin pathways.
• Pharmacological  studies; therapeutic strategies involving receptor agonists and antagonists; pharmacological effects on synaptic physiology, neurotransmitter pathways, neurotrophins and neurohormones.
• Mechanisms of degeneration, plasticity and recovery. Alterations in synaptic function, neurotransmitter function,  trophic factors and neurogenesis  with an emphasis on epilepsy, spinal cord injury, Parkinson’s disease.
• Gene therapy, tissue transplantation including stem cells and  in vivo neurogenesis  in epilepsy, spinal cord injury, Parkinson’s disease.

Study Sections most closely related of similar areas of Science in rank order are:

Acute Neural Injury and Epilepsy [ANIE]
Sensorimotor Integration Study Section [SMI]
Clinical Neuroscience and Neurodegeneration [CNN]
Neurogenesis and Cell Fate Study Section [NCF]